1.1.1.0: Antacids and simeticone

Part of chapter 1 Gastro-Intestinal System, section 1.1 Dyspepsia and gastro-oesophageal reflux disease

High-level prescribing trends for Antacids and simeticone (BNF section 1.1.1.0) across North & East (Iw) PCN for the last five years. You can explore prescribing trends for this section by Sub-ICB Location, or learn more about this site.

View all matching dm+d items.

No prescriptions found.

Do you need help with your analysis? Don't forget to check the FAQ page, and get in touch if you have questions.

Chemicals

Aluminium and magnesium and activated simeticone (0101010L0)
Aluminium and magnesium and oxetacaine (0101010N0)
Aluminium hydroxide (0101010C0)
Calcium carbonate and simeticone (0101010S0)
Co-magaldrox (Magnesium/aluminium hydroxide) (0101010G0)
Co-simalcite (Simeticone/hydrotalcite) (0101010P0)
Hydrotalcite (0101010E0)
Magnesium carbonate (0101010F0)
Magnesium hydroxide (0101010Q0)
Magnesium oxide (0101010I0)
Magnesium sulphate (0101010T0)
Magnesium trisilicate (0101010J0)
Simeticone (0101010R0)
Sodium citrate (0101010U0)
Feedback